Replies to post #610559 on NorthWest Biotherapeutics Inc (NWBO)

[supersteve13]

HL, as you’ve finally dropped your flimsy and poorly executed pretense of being a long here, I have a question. Did you decide to do so on your own because you were failing at it so badly, or was it ordained by your handlers because of any specific recent events? :)

The gas pedal has definitely been pushed harder by many bear/ troll accounts lately so I’m trying to ascertain the reason- thanks!

[CrashOverride]

In fact Flaskworks likely has completed the internal validation tests which have been underway for more than a year. The bridging study could possibly be in process. As far as we know management helped draft the FDA guidance. Linda did write NAFTA and EU Patent Law.

[ilovetech]

HL - In your op, NWBO is at fault for your frustration over the extensive waiting period. While at the same time you agree that the bureaucracy is a crippling obstacle that gets in the way, and a failure at delivering what it's allegedly there to do. So if anyone should be blamed it's you. It's you who underestimated the circumstances under which a new treatment modality would need to overcome. It's you who assumed that management, or any other management could go through the entire process without facing a learning curve, which is obviously the nature of an endeavor of this nature. It's you, who often caused self-inflicted, and unrealistic expectations by your assumptions, as you replaced wishful thinking over realities on the ground. Your job is easy. You had a choice, among unlimited ones to choose from. Not management. It wasn't a dress rehearsal for them. Those who are bitter always find a way to blame and shame the people who are on the front lines, but the devil is in the details, and how leadership responds to adversity. We don't know what would or could have happened during their tenure, if for example, they made a right turn, instead of a left turn, or something, which you have no way of knowing, other than knowing, that you haven't gotten your way soon enough. I would argue that the last thing management would involve themselves with is making choices that would invite hardship, or worse, bankruptcy. Judgement is best made historically, because in the end, it's the outcome that is judged. Nothing else matters. Reality isn't always an easy pill to swallow, but recognition is the next best thing.

ILT

[ae kusterer]

HL: Thanks for this insight .Please list your critic friends with whom you corroborate .

Re: abeta post# 610518

Monday, July 17, 2023 9:46:35 AM

Post#
610559
of 610592
Critical New FDA Guidance for Biologic License Applications and Its Impact on $NWBO DCVax.



Sounds good but here’s a Reality Check:

1. Anyone who works in government can tell you that lots of things change on paper but bureaucrats are very good at limiting the practical effect of those changes. They often amount to window dressing for the same practices to continue behind the illusion of responsiveness to political demands.

In short believe when you see it and any change will probably not occur on a timescale that matters to current investors.

2. Imminent is a worthless word with NWBO as history shows and this time is different until once again it isn’t. To get real, please quantify imminent in terms of days, weeks or months (if it’s years then no sane person would say imminent even an NWBO investor).

3. Flaskworks is clearly not ready for prime time and like the 1st journal article that took forever and appeared in a lower tier journal despite much ballyhoo about a top tier publication or the JAMA article that gummed up TLD release for no benefit (we got to over $2 a share just on spec alone two years earlier and manipulation was supposedly happening then too) Flaskworks will just delay us for little short to medium term benefit compared to opportunity and current costs at best and at worst we’ll wait and then NWBO will bite the bullet and manual production it will be anyhow just with extra steps.